NEXN Q3 2025 Earnings EPS Surges Past Estimates Stock Rises 122 Indaptus Therapeutics Q4 2025 Earnings EPS Misses Estimates on Minimal Revenue Stock Surges Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up XELLL Q1 2026 Earnings Slight EPS Miss Amid Stable Performance Western Copper and Gold Corporation WRN Q1 2026 Earnings EPS Misses Estimates as Development Costs Continue AMPG Q1 2026 Earnings EPS Misses Estimates as Challenges Persist